Exhibit 99.1

Abbott Laboratories

Cardiovascular and Neuromodulation

2016 Comparable Sales*

(unaudited)

 

 

 

2016 Sales ($ in millions)

 

Worldwide

 

1Q

 

2Q

 

3Q

 

4Q

 

FY

 

Rhythm Management and Heart Failure

 

1,021

 

1,089

 

1,034

 

988

 

4,132

 

Cardiovascular and Structural Heart

 

921

 

1,037

 

958

 

981

 

3,897

 

Neuromodulation

 

116

 

140

 

141

 

167

 

564

 

Total Cardiovascular and Neuromodulation

 

2,058

 

2,266

 

2,133

 

2,136

 

8,593

 

 

 

 

2016 Sales ($ in millions)

 

U.S.

 

1Q

 

2Q

 

3Q

 

4Q

 

FY

 

Rhythm Management and Heart Failure

 

570

 

574

 

551

 

488

 

2,183

 

Cardiovascular and Structural Heart

 

368

 

427

 

390

 

388

 

1,573

 

Neuromodulation

 

84

 

97

 

106

 

127

 

414

 

Total Cardiovascular and Neuromodulation

 

1,022

 

1,098

 

1,047

 

1,003

 

4,170

 

 

 

 

2016 Sales ($ in millions)

 

International

 

1Q

 

2Q

 

3Q

 

4Q

 

FY

 

Rhythm Management and Heart Failure

 

451

 

515

 

483

 

500

 

1,949

 

Cardiovascular and Structural Heart

 

553

 

610

 

568

 

593

 

2,324

 

Neuromodulation

 

32

 

43

 

35

 

40

 

150

 

Total Cardiovascular and Neuromodulation

 

1,036

 

1,168

 

1,086

 

1,133

 

4,423

 

 


The following information was filed by Abbott Laboratories (ABT) on Wednesday, January 25, 2017 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Abbott Laboratories's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abbott Laboratories.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account